Sugimoto, Masahiko
Kondo, Mineo
Yasuma, Taro
D’Alessandro-Gabazza, Corina N.
Toda, Masaaki
Imai, Hisanori
Nakamura, Makoto
Gabazza, Esteban C.
Funding for this research was provided by:
Kakenhi Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. (18K09402)
Okasan-Kato Foundation 2017.
Article History
Received: 8 February 2021
Accepted: 4 May 2021
First Online: 17 May 2021
Competing interests
: Masahiko Sugimoto have: [F] Alcon Pharma (class III), Bayer (class III). [I/E/C/P] None. [R] Alcon pharma (class II), Kowa Pharma (class II), Senjyu Pharma (class II), Daiichi Yakuhin Sangyo (class II), Bayer (class II), Wakamoto Pharma (class II).